Longevity Health 2025 Q2 Earnings Significant Loss Reduction

Longevity Health reported its 2025 Q2 earnings on August 14, 2025, showcasing a sharp reduction in losses and a substantial increase in revenue. The results exceeded expectations in key areas, particularly in net income, as the company narrowed its losses year-over-year.

Longevity Health’s Q2 revenue surged by 3987.8% to $503,612 in 2025, compared to $12,320 in the same quarter the previous year. The company significantly reduced its net loss, which fell to $1.89 million from $3.30 million, marking a 42.9% improvement. On a per-share basis, the loss decreased to $1.56 from $4.78, reflecting a 67.4% improvement in profitability.

Revenue
The total revenue of Longevity Health increased by 3987.8% to $503612 in 2025 Q2, up from $12320 in 2024 Q2.

Earnings/Net Income
Longevity Health narrowed losses to $1.56 per share in 2025 Q2 from a loss of $4.78 per share in 2024 Q2 (67.4% improvement). Meanwhile, the company successfully narrowed its net loss to $-1.89 million in 2025 Q2, reducing losses by 42.9% compared to the $-3.30 million net loss reported in 2024 Q2. Remarkably, in 2025 Q2, the company set a new record high for fiscal Q2 net income, the highest in 1 years. The narrowing of both per-share and absolute losses represents a meaningful step toward long-term financial sustainability.

Price Action
The stock price of Longevity Health has edged down 2.08% during the latest trading day, has plummeted 16.96% during the most recent full trading week, and has plummeted 58.77% month-to-date.

Post-Earnings Price Action Review
The strategy of buying Longevity Health (XAGE) shares 30 days after quarterly earnings releases and holding until the next earnings release has shown strong performance over the past three years. The approach has delivered an average return of 24.76% per quarter, with a total cumulative return of 189.78% over 12 quarters. This compares favorably to the S&P 500's cumulative return of 104.57% over the same period, highlighting the effectiveness of this strategy in generating robust returns on XAGE.

CEO Commentary
CEO John Mitchell emphasized that Longevity Health is making meaningful progress in advancing aging research, citing recent breakthroughs such as the development of a biological clock based on blood measurements and an improved mouse model for systemic aging-related decline. He acknowledged the challenges of scaling these innovations into clinical applications but expressed optimism about the long-term potential of the company’s science-driven approach. Mitchell highlighted the growing global demand for longevity solutions, aligning the company’s mission with the principles of the longevity economy, including healthy aging and financial resilience. He stressed that strategic investments in R&D and partnerships with academic and industry leaders are central to positioning Longevity Health as a leader in the field. Despite the current financial losses, Mitchell conveyed a forward-looking and cautiously optimistic tone about the company’s trajectory.

Guidance
Longevity Health expects continued R&D investment and anticipates increased collaboration in the aging research space, though the company did not provide specific quantitative guidance for revenue or EPS in the current quarter. The CEO reiterated a focus on long-term value creation through scientific innovation rather than short-term financial metrics.

Additional News
In Nigeria, the Economic and Financial Crimes Commission (EFCC) arrested five individuals for illegal mining in Akwa Ibom, signaling increased enforcement against economic crimes. Additionally, the EFCC denied targeting former President Olusegun Obasanjo in a recent sting operation, as it arraigned suspects in court. Political tensions also flared as Nigeria’s two dominant political parties, the Peoples Democratic Party (PDP) and the All Progressives Congress (APC), rejected a Canadian court ruling labeling them as terrorist organizations. Meanwhile, police operations across the country continued to intensify, with armed robbers operating from Lagos refuse dumps being successfully neutralized.